These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32765165)

  • 1. Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive crisis in sickle cell patients in the emergency department.
    Paquin H; Trottier ED; Pastore Y; Robitaille N; Dore Bergeron MJ; Bailey B
    Paediatr Child Health; 2020 Aug; 25(5):293-299. PubMed ID: 32765165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral morphine protocol evaluation for the treatment of vaso-occlusive crisis in paediatric sickle cell patients.
    Paquin H; D Trottier E; Robitaille N; Pastore Y; Dore Bergeron MJ; Bailey B
    Paediatr Child Health; 2019 Feb; 24(1):e45-e50. PubMed ID: 30792609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
    Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
    Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department.
    Schefft MR; Swaffar C; Newlin J; Noda C; Sisler I
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27274. PubMed ID: 29856534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.
    Fein DM; Avner JR; Scharbach K; Manwani D; Khine H
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27862905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
    Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
    Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
    CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
    Admiraal M; van Daalen J; Ritt MWJ; Dekker J; van Tuijn CFJ; Nur E; Hollmann MW; Hermanns H; Hermanides J; Biemond BJ
    Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.
    Luo L; King AA; Carroll Y; Baumann AA; Brambilla D; Carpenter CR; Colla J; Gibson RW; Gollan S; Hall G; Klesges L; Kutlar A; Lyon M; Melvin CL; Norell S; Mueller M; Potter MB; Richesson R; Richardson LD; Ryan G; Siewny L; Treadwell M; Zun L; Armstrong-Brown J; Cox L; Tanabe P
    JMIR Res Protoc; 2021 Apr; 10(4):e24818. PubMed ID: 33861209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Emergency Department Management of Sickle Cell Vaso-Occlusive Pain Crisis: The Role and Options of Sublingual and Intranasally Administered Analgesia.
    Ojo AS; Odipe OG; Owoseni O
    J Clin Med Res; 2023 Jan; 15(1):10-22. PubMed ID: 36755761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: A multicenter pediatric emergency medicine perspective.
    Rees CA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown KM; Casper TC; Chapman LL; Chumpitazi CE; Cohen DM; Dampier C; Ellison AM; Grasemann H; Hatabah D; Hickey RW; Hsu LL; Bakshi N; Leibovich S; Patil P; Powell EC; Richards R; Sarnaik S; Weiner DL; Morris CR;
    Am J Hematol; 2023 Apr; 98(4):620-627. PubMed ID: 36606705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of an adaptive randomized clinical trial of intravenous citrulline for sickle cell pain crisis in the emergency department.
    Majumdar S; McKinley KW; Chamberlain J; Thomas B; Margulies S; Nickel RS; Darbari DS; Campbell A; Berul C; Summar M; Kalsi G
    Contemp Clin Trials Commun; 2023 Apr; 32():101077. PubMed ID: 36698745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.
    Tanabe P; Hafner JW; Martinovich Z; Artz N
    Acad Emerg Med; 2012 Apr; 19(4):430-8. PubMed ID: 22506947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease.
    Inoue S; Khan I; Mushtaq R; Sanikommu SR; Mbeumo C; LaChance J; Roebuck M
    Ann Hematol; 2016 Jan; 95(2):221-5. PubMed ID: 26611852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.
    Barrett MJ; Cronin J; Murphy A; McCoy S; Hayden J; an Fhailí S; Grant T; Wakai A; McMahon C; Walsh S; O'Sullivan R
    Trials; 2012 May; 13():74. PubMed ID: 22647439
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.